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Sir: I would like to disagree strongly with 
the conclusions reached by the authors of 
this paper, namely that early nasal CPAP is 
good for VLBW infants. The data, for a 
start, are not part of an adequate control 
trial. Sequential studies of this nature can 
never be an acceptable way of evaluating 
advances in neonatal therapy. This is high- 
lighted in this case by the fact that there was 
a marked increase in the two time periods in 
the use of antenatal steroids, from 49.1% in 
1990, to 70% in 1993. Since antenatal 
steroids in babies of this birthweight and 
gestation are likely to result in something 
like a 50% decrease in the incidence and 
severity of respiratory distress syndrome, 
this change in their local practice on its own 
would be sufficient to result in the improved 
outcome. 
For a topic that is a matter of consid- 
erable controversy at present in European 
neonatology, I believe it is unfortunate 
when papers are published which are not 
adequately designed to answer the relevant 
questions. 
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Sir: As indicated in our paper we controlled 
for the confounding effects of several vari- 
ables with multiple logistic regression anal- 
ysis which demonstrated that not antenatal 
lung maturation but rather nasal CPAP 
treatment was the predominating cause for 
the lower intubation rate in the CPAP 
group. Table 1 below shows the proportion 
of intubated infants with and without 
antenatal lung maturation in the two study 
groups, respectively. It provides the data to 
perform a Cochran's test [1] which also 
shows that the significant decrease in intu- 
bation rate following early nasal CPAP 
treatment persists when prenatal lung mat- 
uration is taken into account. 
With respect to frequency and severity 
of respiratory distress, the two groups in 
our study did not differ significantly (signs 
and symptoms of respiratory distress 
prompting treatment were present in 77.2% 
vs. 78.6% in two groups). We fully agree 
with Dr. Roberton that randomized con- 
trolled trials would provide the strongest 
evidence for or against the benefit of early 
nasal CPAP in VLBW infants, as was 
stated in the very last sentence of our paper. 
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Table 1. Confounding effect of 
prenatal lung maturation on 
intubation rate 
Prenatal 1990 1993 p-value a 
lung maturation (Control-group) (NCPAP-group) (Cochran's test) 
Intubated (%) Intubated (%) 
infants/subgroup infants/subgroup 
Yes 14/28 (50) 12/49 (24) 
No 16/29 (55) 9/21 (43) 
0.018 < P < 0.025 
a The mean difference of proportion of intubated infants between the two study groups weighted for 
prenatal lung maturation is 20.15% 
